Brief Profile

Diss Brief Profile

The Brief Profile summarizes the non-confidential data on substances as it is held in the databases of the European Chemicals Agency (ECHA), including data provided by third parties. The Brief Profile is automatically generated; note that it does not currently distinguish between harmonised classification and minimum classification; information requirements under different legislative frameworks may therefore not be fully up to date or complete. For accuracy reasons, substance manufacturers and imports have the responsibility to consult official sources, e.g. the electronic edition of the Official Journal of the European Union.
This Brief Profile is covered by the ECHA Legal Notice.

Substance Description

Substance identity

EC / List no.:
413-180-4
CAS no.:
187285-15-0
Index number:
611-060-00-8
Molecular formula:
SMILES:
InChI:
Type of substance:
Origin:
Registered compositions:
2
Of which contain:
0 impurities relevant for classification
0 additives relevant for classification
Substance Listed:
ELINCS (European LIst of Notified Chemical Substances) List

Hazard classification & labelling

Danger! According to the harmonised classification and labelling (CLP00) approved by the European Union, this substance causes serious eye damage.

Breakdown of all 116 C&L notifications submitted to ECHA

Eye Dam. 1 H318 Harmonised Classification
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

https://www.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/tick.png Harmonised Classification

https://www.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/Reach.png REACH registration dossiers notifications

https://www.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/CLP.png CLP notifications

Properties of concern

Regulatory context

Registration, Evaluation, Authorisation & Restriction of Chemicals (REACH)

Registration
Pre-registration:
Substance pre-registered under REACH.
Registration:
This substance has 2 active registrations under REACH, 1 Joint Submission(s) and 0 Individual Submission(s).
Please see Registrants/Suppliers details.
Evaluation
Dossier Evaluation:
Substance Evaluation:
Authorisation
Candidate List:
Annex XIV (Authorisation List):
Restriction
Annex XVII (Restriction List):

Persistent Organic Pollutants Regulation (POPs)

List of substances subject to the POPs Regulation:
List of substances proposed as POPs:

Classification Labelling & Packaging (CLP)

Harmonised C&L:
A European Union Harmonised Classification & Labelling has been assigned to this substance.
Seveso Annex I:
Notified C&L:
Classification & Labelling has been notified by industry to ECHA for this substance.

Biocidal Products Regulation (BPR)

Active Substance:
Biocidal Products:

Prior Informed Consent (PIC)

Annex I:
Annex V:

European Union Observatory for Nanomaterials (EUON)

EUON:

About this substance

This substance is registered under the REACH Regulation and is manufactured in and / or imported to the European Economic Area, but the tonnage data is confidential.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data indicating whether or into which articles the substance might have been processed.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the types of manufacture using this substance.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the types of manufacture using this substance.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

Precautions for using this substance have been recommended by its registrants under REACH, as follows:

Prevention statements

When handling this substance: wear protective gloves and/or clothing, and eye and/or face protection as specified by manufacturer/supplier.

Response statements

In case of incident: If in eyes: rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing. Immediately call a poison center or doctor/physician.

Guidance on the safe use of the substance provided by manufacturers and importers of this substance.

Registrants/suppliers

  • Former NONS notifier unknown to ECHA - Contact the relevant UK competent national authority., null
  • Fujifilm Europe GmbH (OR2), Heesenstr. 31 40549 Düsseldorf NRW Germany

Substance names and other identifiers

A mixture of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid
EC Inventory, Other
A mixture of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid
C.I. DIRECT VIOLET 107; PRO-JET FAST MAGENTA 2 COLOUR; S161629
REACH pre-registration, Other
C.I. Direct violet 107
C.I. DIRECT VIOLET 107; PRO-JET FAST MAGENTA 2 COLOUR; S161629
Other
reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid
C.I. DIRECT VIOLET 107; PRO-JET FAST MAGENTA 2 COLOUR; S161629
C&L Inventory
reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy 3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid
C.I. DIRECT VIOLET 107; PRO-JET FAST MAGENTA 2 COLOUR; S161629
CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances, Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, Medical Devices Regulation - Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties
Blanding af: natrium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophtalat ammonium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophtalat 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatnaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatnaphthalen-2-ylazo]-isophthalsyre (da)
C&L Inventory
blanding av: natrium-5-[8-[4-[4-[4-[7-(3,5-dikarboksylatofenylazo)-8-hydroksy-3,6-disulfonatonaftalen-1-ylamino]-6-hydroksy-1,3,5-triazin-2-yl]-2,5-dimetylpiperazin-1-yl]-6-hydroksy-1,3,5-triazin-2-ylamino]-1-hydroksy-3,6-disulfonatonaftalen-2-ylazo]isoftalat ammonium-5-[8-[4-[4-[4-[7-(3,5-dikarboksylatofenylazo)-8-hydroksy-3,6-disulfonatonaftalen-1-ylamino]-6-hydroksy-1,3,5-triazin-2-yl]-2,5-dimetylpiperazin-1-yl]-6-hydroksy-1,3,5-triazin-2-ylamino]-1-hydroksy-3,6-disulfonatonaftalen-2-ylazo]isoftalat 5-[8-[4-[4-[4-[7-(3,5-dikarboksylatofenylazo)-8-hydroksy-3,6-disulfonatonaftalen-1-ylamino]-6-hydroksy-1,3,5-triazin-2-yl]-2,5-dimetylpiperazin-1-yl]-6-hydroksy-1,3,5-triazin-2-ylamino]-1-hydroksy-3,6-disulfonaftalen-2-ylazo]isoftalsyre (no)
C&L Inventory
Blandning av: natrium-5-[8-[4-[4-[4-[7-(3,5-dikarboxylatofenylazo)-8-hydroxi-3,6-disulfonatonaftalen-1-ylamino]-6-hydroxi-1,3,5-triazin-2-yl]-2,5-dimetylpiperazin-1-yl]-6-hydroxi-1,3,5-triazin-2-ylamino]-1-hydroxi-3,6-disulfonatonaftalen-2-ylazo]isoftalat ammonium-5-[8-[4-[4-[4-[7-(3,5-dikarboxylatofenylazo)-8-hydroxi-3,6-disulfonatonaftalen-1-ylamino]-6-hydroxi-1,3,5-triazin-2-yl]-2,5-dimetylpiperazin-1-yl]-6-hydroxi-1,3,5-triazin-2-ylamino]-1-hydroxi-3,6-disulfonatonaftalen-2-ylazo]isoftalat 5-[8-[4-[4-[4-[7-(3,5-dikarboxylatofenylazo)-8-hydroxi-3,6-disulfonatonaftalen-1-ylamino]-6-hydroxi-1,3,5-triazin-2-yl]-2,5-dimetylpiperazin-1-yl]-6-hydroxi-1,3,5-triazin-2-ylamino]-1-hydroxi-3,6-disulfonatonaftalen-2-ylazo]isoftalsyra (sv)
C&L Inventory
masa de reactie a: sodiu 5-[8-[4-[4-[4-[7-(3,5-dicarboxilatofenilazo)-8-hidroxi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroxi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroxi-1,3,5-triazin-2-ilamino]-1-hidroxi-3,6- disulfonatonaftalen-2-ilazo]-izoftalate amoniu 5-[8-[4-[4-[4-[7-(3,5-dicarboxilatofenilazo)-8-hidroxi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroxi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroxi-1,3,5-triazin-2-ilamino]-1-hidroxi-3,6-disulfonatonaftalen-2-ilazo]-izoftalat 5-[8-[4-[4-[4-[7-(3,5-dicarboxilatofenilazo)-8-hidroxi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroxi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroxi-1,3,5-triazin-2-ilamino]-1-hidroxi-3,6-disulfonaftalen-2-ilazo]-acid izoftalic (ro)
C&L Inventory
masse de réaction de: 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophénylazo)-8-hydroxy-3,6-disulfonatonaphtalén-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-diméthylpipérazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphtalén-2-ylazo]-isophtalate de sodium;5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophénylazo)-8-hydroxy-3,6-disulfonatonaphtalén-1-ylamino]-6-hydroxy1,3,5-triazin-2-yl]-2,5-diméthylpipérazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphtalén-2-ylazo]-isophtalate d'ammonium;acide 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophénylazo)-8-hydroxy-3,6-disulfonatonaphtalén-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-diméthylpipérazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphtalén-2-ylazo]-isophtalique 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophénylazo)-8-hydroxy-3,6-disulfonatonaphtalén-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-diméthylpipérazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphtalén-2-ylazo]-isophtalate d' ammonium acide 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophénylazo)-8-hydroxy-3,6-disulfonatonaphtalén-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-diméthylpipérazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphtalén-2-ylazo]-isophtalique (fr)
C&L Inventory
Mengsel van: natrium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylaat-fenylazo)-8-hydroxy-3,6-disulfonatonaftaleen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaatnaftalen-2-ylazo]-isoftalaat ammonuim-5-[8-[4-[4-[4-[7-(3,5-dicarboxylaat-fenylazo)-8-hydroxy-3,6-disulfonatonaftaleen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaatnaftalen-2-ylazo]-isoftalaat 5-[8-[4-[4-[4-[7-(3,5-dicarboxylaat-fenylazo)-8-hydroxy-3,6-disulfonatonaftaleen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaatnaftalen-2-ylazo]-isoftaalzuur (nl)
C&L Inventory
Mezcla de: 5-[8-[4-[4-[4-[7-(3,5-dicarboxilatofenilazo)-8-hidroxi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroxi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroxi-1,3,5-triazin-2-ilamino]-1-hidroxi-3,6-disulfonatonaftalen-2-ilazo]-isoftalato de sodio 5-[8-[4-[4-[4-[7-(3,5-dicarboxilatofenilazo)-8-hidroxi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroxi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroxi-1,3,5-triazin-2-ilamino]-1-hidroxi-3,6-disulfonatonaftalen-2-ilazo]-isoftalato de amonio ácido 5-[8-[4-[4-[4-[7-(3,5-dicarboxilatofenilazo)-8-hidroxi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroxi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroxi-1,3,5-triazin-2-ilamino]-1-hidroxi-3,6-disulfonatonaftalen-2-ilazo]-isoftálico (es)
C&L Inventory
mieszanina poreakcyjna: 5-{8-[4-(4-{4-[7-(3,5-dikarboksylano-fenyloazo)-8-hydroksy-3,6-disulfoniano-naftalen-1-yloamino]-6-hydroksy-1,3,5-triazyn-2-ylo}-2,5-dimetylo-piperazyn-1-ylo)-6-hydroksy-1,3,5-triazyn-2-yloamino]-1-hydroksy-3,6-disulfonianonaftalen-2-yloazo}-izoftalanu sodu, 5-{8-[4-(4-{4-[7-(3,5-dikarboksylano-fenyloazo)-8-hydroksy-3,6-disulfoniano-naftalen-1-yloamino]-6-hydroksy-1,3,5-triazyn-2-ylo}-2,5-dimetylo-piperazyn-1-ylo)-6-hydroksy-1,3,5-triazyn-2-yloamino]-1-hydroksy-3,6-disulfonianonaftalen-2-yloazo}-izoftalanu amonium kwasu 5-{8-[4-(4-{4-[7-(3,5-di-karboksylanofenyloazo)-8-hydroksy-3,6-disulfonianonaftalen-1-yloamino]-6-hydroksy-1,3,5-triazyn-2-ylo}-2,5-dimetylopiperazyn-1-ylo)-6-hydroksy-1,3,5-triazyn-2-yloamino]-1-hydroksy-3,6-disulfonaftalen-2-yloazo]izoftalowego (pl)
C&L Inventory
Miscela di: 5-[8-[4-[4-[4-[7-(3,5-dicarbossilatofenilazo)-8-idrossi-3,6-disolfonatonaftalen-1-ilammino]-6-idrossi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-idrossi-1,3,5-triazin-2-ilammino]-1-idrossi-3,6-disolfonatonaftalen-2-ilazo]-isoftalato di sodio 5-[8-[4-[4-[4-[7-(3,5-dicarbossilatofenilazo)-8-idrossi-3,6-disolfonatonaftalen-1-ilammino]-6-idrossi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-idrossi-1,3,5-triazin-2-ilammino]-1-idrossi-3,6-disolfonatonaftalen-2-ilazo]-isoftalato d'ammonio acido 5-[8-[4-[4-[4-[7-(3,5-dicarbossilatofenilazo)-8-idrossi-3,6-disolfonatonaftalen-1-ilammino]-6-idrossi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-idrossi-1,3,5-triazin-2-ilammino]-1-idrossi-3,6-disolfonaftalen-2-ilazo]-isoftalico (it)
C&L Inventory
Mistura de: 5-[8-[4-[4-[4-[7-(3,5-dicarboxilatofenilazo)-2-hidroxi-3,6-dissulfonatonaftaleno-1-ilamino]-6-hidroxi-1,3,5-triazina-2-il]-2,5-dimetilpiperazina-1-il]-6-hidroxi-1,3,5-triazina-2-ilamino]-1-hidroxi-3,6-dissulfonatonaftaleno-2-ilazo]-isoftalato de sódio 5-[8-[4-[4-[4-[7-(3,5-dicarboxilatofenilazo)-8-hidroxi-3,6-dissulfonatonaftaleno-1-ilamino]-6-hidroxi-1,3,5-triazina-2-il]-2,5-dimetilpiperazina-1-il]-6-hidroxi-1,3,5-triazina-2-ilamino]-1-hidroxi-3,6-dissulfonatonaftaleno-2-ilazo]-isoftalato de amónio ácido 5-[8-[4-[4-[4-[7-(3,5-dicarboxilatofenilazo)-8-hidroxi-3,6-dissulfonatonaftaleno-1-ilamino]-6-hidroxi-1,3,5-triazina-2-il]-2,5-dimetilpiperazina-1-il]-6-hidroxi-1,3,5-triazina-2-ilamino]-1-hidroxi-3,6-dissulfonatonaftaleno-2-ilazo]-isoftálico (pt)
C&L Inventory
mišinys: natrio 5-[8-[4-[4-[4-[7-(3,5-dikarboksilatfenilazo)-8-hidroksi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroksi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroksi-1,3,5-triazin-2-ilamino]-1-hidroksi-3,6-disulfonato-naftalen-2-ilazo]-izoftalato amonio 5-[8-[4-[4-[4-[7-(3,5-dikarboksilatfenilazo)-8-hidroksi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroksi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroksi-1,3,5-triazin-2-ilamino]-1-hidroksi-3,6-disulfonatonaftalen-2-ilazo]-izoftalato 5-[8-[4-[4-[4-[7-(3,5-dikarboksilatfenilazo)-8-hidroksi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroksi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroksi-1,3,5-triazin-2-ilamino]-1-hidroksi-3,6-disulfonatoftalen-2-ilazo]-izoftalio rūgšties (lt)
C&L Inventory
Mίγμα από: 5-[8-[4-[4-[4-[7-(3,5-δικαρβoξυλικoφαινυλαζω)-8-υδρoξυ-3,6-δισoυλφoνικoναφθαλεν-1-υλαμινo]-6-υδρoξυ-[1,3,5]-τριαζιν-2-υλo]-2,5-διμεθυλoπιπεραζιν-1-υλo]-6-υδρoξυ-[1,3,5]-τριαζιν-2-υλαμινo]-1-υδρoξυ-3,6-δισoυλφoνικoναφθαλεν-2-υλαζω]-ισoφθαλικό νάτριο 5-[8-[4-[4-[4-[7-(3,5-δικαρβoξυλικoφαινυλαζω)-8-υδρoξυ-3,6-δισoυλφoνικoναφθαλεν-1-υλαμινo]-6-υδρoξυ-1,3,5-τριαζιν-2-υλo]-2,5-διμεθυλoπιπεραζιν-1-υλo]-6-υδρoξυ-1,3,5-τριαζιν-2-υλαμινo]-1-υδρoξυ-3,6-δισoυλφoνικoναφθαλεν-2-υλαζω]-ισoφθαλικό αμμώνιο 5-[8-[4-[4-[4-[7-(3,5-δικαρβoξυλικοφαινυλαζω)-8-υδρoξυ-3,6-δισoυλφoνικoναφθαλεν-1-υλαμινo]-6-υδρoξυ-1,3,5-τριαζιν-2-υλo]-2,5-διμεθυλoπιπεραζιν-1-υλo]-6-υδρoξυ-1,3,5-τριαζιν-2-υλαμινo]-1-υδρoξυ-3,6-δισoυλφoνικoναφθαλεν-2-υλαζω]-ισoφθαλικό oξύ (el)
C&L Inventory
nátrium-5-[8-[4-[4-[4-[7-(3,5-dikarboxilátofenilazo)-8-hidroxi-3,6-diszulfonátonaftalin-1-ilamino]-6-hidroxi-1,3,5-triazin-2-il]-2,5- dimetilpiperazin-1-il]-6-hidroxi-1,3,5-triazin-2-ilamino]-1-hidroxi-3,6- diszulfonátonaftalin-2-ilazo]izoftalát ammónium-5-[8-[4-[4-[4-[7-(3,5-dikarboxilátofenilazo)-8-hidroxi-3,6-diszulfonátonatfalin-1-ilamino]-6-hidroxi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroxi-1,3,5- triazin-2-ilamino]-1-hidroxi-3,6- diszulfonátonaftalin-2-ilazo]izoftalát 5-[8-[4-[4-[4-[7-(3,5-dikarboxilátofenilazo)-8-hidroxi-3,6-diszulfonátonaftalin-1-ilamino]-6-hidroxi-1,3,5-triazin-2-il]-2,5-dimetilpiperazin-1-il]-6-hidroxi-1,3,5- triazin-2-ilamino]-1-hidroxi-3,6-diszulfonaftalin-2-ilazo]-izoftálsav keveréke (hu)
C&L Inventory
nātrija 5-[8-[4-[4-[4-[7-(3,5-dikarboksilatofenilazo)-8-hidroksi-3,6-disulfonātnaftalīn-1-ilamino]-6-hidroksi-1,3,5-triazin-2-il]-2,5-dimetilpiperazīn-1-il]-6-hidroksi-1,3,5-triazin-2-ilamino]-1-hidroksi-3,6-disulfonātnaftalīn-2-ilazo]izoftalāta, amonija 5-[8-[4-[4-[4-[7-(3,5-dikarboksilatofenilazo)-8-hidroksi-3,6-disulfonātnaftalīn-1-ilamino]-6-hidroksi-1,3,5-triazin-2-il]-2,5-dimetilpiperazīn-1-il]-6-hidroksi-1,3,5-triazin-2-ilamino]-1-hidroksi-3,6-disulfonātnaftalīn-2-ilazo]-izoftalāta un 5-[8-[4-[4-[4-[7-(3,5-dikarboksilatofenilazo)-8-hidroksi-3,6-disulfonātnaftalīn-1-ilamino]-6-hidroksi-1,3,5-triazin-2-il]-2,5-dimetilpiperazīn-1-il]-6-hidroksi-1,3,5-triazin-2-ilamino]-1-hidroksi-3,6-disulfonaftalīn-2-ilazo]-izoftalskābes maisījums (lv)
C&L Inventory
Reaction mass aus: Natrium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalin-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalin-2-ylazo]-isophthalat, Ammonium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalin-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalin-2-ylazo]-isophthalat und 5-[8-[4-[4-[4-[7-(3,5-Dicarboxylatphenylazo)-8-hydroxy-3,6-disulfonatonaphthalin-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalin-2-ylazo]-isophthalsäure (de)
C&L Inventory
reakčná zmes zložená z týchto látok: sodná soľ kyseliny 5-{8-[4-(4-{4-[7-(3,5-dikarboxyfenyldiazenyl)-8-hydroxy-3,6-disulfonaftalén-1-ylamino]-6-hydroxy-1,3,5-triazín-2-yl}-2,5-dimetylpiperazín-1-yl)-6-hydroxy-1,3,5-triazín-2-ylamino]-1-hydroxy-3,6-disulfonaftalén-2-yldiazenyl}izoftalovej amónna soľ kyseliny 5-{8-[4-(4-{4-[7-(3,5-dikarboxyfenyldiazenyl)-8-hydroxy-3,6-disulfonaftalén-1-ylamino]-6-hydroxy-1,3,5-triazín-2-yl}-2,5-dimetylpiperazín-1-yl)-6-hydroxy-1,3,5-triazín-2-ylamino]-1-hydroxy-3,6-disulfonaftalén-2-yldiazenyl}izoftalovej kyselina 5-{8-[4-(4-{4-[7-(3,5-dikarboxyfenyldiazenyl)-8-hydroxy-3,6-disulfonaftalén-1-ylamino]-6-hydroxy-1,3,5-triazín-2-yl}-2,5-dimetylpiperazín-1-yl)-6-hydroxy-1,3,5-triazín-2-ylamino]-1-hydroxy-3,6-disulfonaftalén-2-yldiazenyl}izoftalová (sk)
C&L Inventory
reakční směs: natrium-5-{8-[4-(4-{4-[7-(3,5-dikarboxylatofenylazo)-8-hydroxy-3,6-disulfonato-1-naftylamino]-6-hydroxy-1,3,5-triazin-2-yl}-2,5-dimethylpiperazin-1-yl)-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonato-2-naftylazo}-isoftalát amonium-5-{8-[4-(4-{4-[7-(3,5-dikarboxylatofenylazo)-8-hydroxy-3,6-disulfonato-1-naftylamino]-6-hydroxy-1,3,5-triazin-2-yl}-2,5-dimethylpiperazin-1-yl)-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonato-2-naftylazo}-isoftalát 5-{8-[4-(4-{4-[7-(3,5-dikarboxylatofenylazo)-8-hydroxy-3,6-disulfonato-1-naftylamino]-6-hydroxy-1,3,5-triazin-2-yl}-2,5-dimethylpiperazin-1-yl)-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonato-2-naftylazo}-isoftalová kyselina (cs)
C&L Inventory
Seos: natrium-5-[8-[4-[4-[4-[7-(3,5-dikarboksylaatti-fenyyliatso)-8-hydroksi-3,6-disulfonaattonaftalen-1-yyliamino]-6-hydroksi-1,3,5-triatsin-2-yyli]-2,5-dimetyylipiperatsiini-1-yyli]-6-hydroksi-1,3,5-triatsin-2-yyliamino]-1-hydroksi-3,6-disulfonaattonaftalen-2-yyliatso]isoftalaatti ammonium- 5-[8-[4-[4-[4-[7-(3,5-dikarboksylaattifenyyliatso)-8-hydroksi-3,6-disulfonaattonaftalen-1-yyliamino]-6-hydroksi-1,3,5-triatsin-2-yyli]-2,5-dimetyylipiperatsiini-1-yyli]-6-hydroksi-1,3,5-triatsin-2-yyliamino]-1-hydroksi-3,6-disulfonaattonaftalen-1-yyliatso]isoftalaatti 5-[8-[4-[4-[4-[7-(3,5-dikarboksylaattofenyyliatso)-8-hydroksi-3,6-disulfonaattonanaftalen-1-yyliamino]-6-hydroksi-1,3,5-triatsin-2-yyli]-2,5-dimetyylipiperatsiini-1-yyli]-6-hydroksi-1,3,5-triatsin-2-yyliamino]-1-hydroksi-3,6-disulfonaattonaftalen-2-yyliatso]isoftaalihappo (fi)
C&L Inventory
zmes: natrijev 5-{8-[4-(4-{4-[7-(3,5-dikarboksilatofenilazo)-8-hidroksi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroksi-1,3,5-triazin-2-il}-2,5-dimetilpiperazin-1-il)-6-hidroksi-1,3,5-triazin-2-ilamino]-1-hidroksi-3,6-disulfonatonaftalen-2-ilazo}-izoftalat amonijev 5-{8-[4-(4-{4-[7-(3,5-dikarboksilatofenilazo)-8-hidroksi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroksi-1,3,5-triazin-2-il}-2,5-dimetilpiperazin-1-il)-6-hidroksi-1,3,5-triazin-2-ilamino]-1-hidroksi-3,6-disulfonatonaftalen-2-ilazo}-izoftalat 5-{8-[4-(4-{4-[7-(3,5-dikarboksilatofenilazo)-8-hidroksi-3,6-disulfonatonaftalen-1-ilamino]-6-hidroksi-1,3,5-triazin-2-il}-2,5-dimetilpiperazin-1-il)-6-hidroksi-1,3,5-triazin-2-ilamino]-1-hidroksi-3,6-disulfonaftalen-2-ilazo}-izoftalna kislina (sl)
C&L Inventory
реакционна маса от: натриев-5-[8-[4-[4-[4-[7-(3,5-дикарбоксилатофенилазо)-8-хидрокси-3,6-дисулфонатонафталeн-1-иламино]-6-хидрокси-1,3,5-триазин-2-ил]-2,5-диметилпиперазин-1-ил]-6-хидрокси-1,3,5-триазин-2-иламино]-1-хидрокси-3,6-дисулфонатонафталeн-2-илазо]-изофталат амониев-5-[8-[4-[4-[4-[7-(3,5-дикарбоксилатофенилазо)-8-хидрокси-3,6-дисулфонатонафталeн-1-иламино]-6-хидрокси-1,3,5-триазин-2-ил]-2,5-диметилпиперазин-1-ил]-6-хидрокси-1,3,5-триазин-2-иламино]-1-хидрокси-3,6-дисулфонатонафталeн-2-илазо]-изофталат 5-[8-[4-[4-[4-[7-(3,5-дикарбоксилат-фенилазо)-8-хидрокси-3,6-дисулфонатонафталeн-1-иламино]-6-хидрокси-1,3,5-триазин-2-ил]-2,5-диметилпиперазин-1-ил]-6-хидрокси-1,3,5-триазин-2-иламино]-1-хидрокси-3,6-дисулфонатонафталeн-2-илазо]-изофталова киселина (bg)
C&L Inventory
5-(2-{8-[(4-{4-[4-({7-[2-(3,5-dicarboxyphenyl)diazen-1-yl]-8-hydroxy-3,6-disulfonaphthalen-1-yl}amino)-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl}-6-hydroxy-1,3,5-triazin-2-yl)amino]-1-hydroxy-3,6-disulfonaphthalen-2-yl}diazen-1-yl)benzene-1,3-dicarboxylic acid amine sodium hydride
Other
eaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-yl ...
C&L Inventory
Pro-Jet Fast Magenata 2 Liquid
Registration dossier
CI DIRECT VIOLET 107
Registration dossier
PRO-JET FAST MAGENTA 2 COLOUR
Registration dossier
S161629
Registration dossier
187285-15-0
CAS number
C&L Inventory, Other, CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances, Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, Medical Devices Regulation - Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties
611-060-00-8
Index number
C&L Inventory

Scientific properties

Physical and chemical properties

This section provides physicochemical information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Appearance/physical state / colour

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Melting/freezing point

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Boiling point

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Density

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Vapour pressure

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Partition coefficient

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Water solubility

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Solubility in organic solvents / fat solubility

Data not provided by the registrant

Surface tension

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Flash point

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Auto flammability

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Flammability

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Explosiveness

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidising

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidation reduction potential

Data not provided by the registrant

pH

Data not provided by the registrant

Dissociation constant

Data not provided by the registrant

Viscosity

Data not provided by the registrant

Environmental fate and pathways

This section provides environmental fate and pathways information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Phototransformation in air

Data not provided by the registrant

Hydrolysis

Study results
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Phototransformation in water

Data not provided by the registrant

Phototransformation in soil

Data not provided by the registrant

Biodegradation in water - screening tests

Study results
  • 4 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 4
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Biodegradation in water & sediment - simulation tests

Data not provided by the registrant

Biodegradation in soil

Data not provided by the registrant

Bioaccumulation: aquatic / sediment

Data not provided by the registrant

Bioaccumulation: terrestrial

Data not provided by the registrant

Adsorption/desorption

Data not provided by the registrant

Henrys law constant (H)

Data not provided by the registrant

Distribution modelling

Data not provided by the registrant

Ecotoxicological information

This section provides ecotoxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Predicted No-Effect Concentration (PNEC)

Data not provided by the registrant

Short–term toxicity to fish

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Long–term toxicity to fish

Data not provided by the registrant

Short–term toxicity to aquatic invertebrates

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Long–term toxicity to aquatic invertebrates

Data not provided by the registrant

Toxicity to aquatic algae and cyanobacteria

Study results
  • 4 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 4
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to aquatic plants other than algae

Data not provided by the registrant

Toxicity to microorganisms

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Sediment toxicity

Data not provided by the registrant

Endocrine disrupter testing in aquatic vertebrates – in vivo

Data not provided by the registrant

Toxicity to terrestrial macroorganisms except arthropods

Data not provided by the registrant

Toxicity to terrestrial arthropods

Data not provided by the registrant

Toxicity to terrestrial plants

Data not provided by the registrant

Toxicity to soil microorganisms

Data not provided by the registrant

Toxicity to birds

Data not provided by the registrant

Toxicity to mammals

Data not provided by the registrant

Toxicological information

This section provides toxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Derived No- or Minimal Effect Level (DN(M)EL)

Data not provided by the registrant

Toxicokinetics, metabolism, and distribution

Study results
Study data: basic toxicokinetics
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: basic toxicokinetics
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Study data: dermal absorption
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: dermal absorption
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Acute toxicity

Study results
oral
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
oral
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
inhalation
  • 0 studies submitted
  • 0 studies processed

No data available

inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
dermal
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

dermal
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
other routes
  • 0 studies submitted
  • 0 studies processed

No data available

other routes
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Irritation / corrosion

Study results
Study data: skin
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Study data: eye
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: eye
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Sensitisation

Study results
Study data: skin
  • 4 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study
Supporting study
Weight of evidence
Other 4
Data waiving
no waivers
Study data: respiratory
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: respiratory
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Repeated dose toxicity

Study results
Study data: oral
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Study data: oral
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Study data: inhalation
  • 0 studies submitted
  • 0 studies processed

No data available

Study data: inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Study data: dermal
  • 0 studies submitted
  • 0 studies processed

No data available

Study data: dermal
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Genetic toxicity

Study results
Study data: in vitro
  • 4 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: in vitro
Studies with data
Key study
Supporting study
Weight of evidence
Other 4
Data waiving
no waivers
Study data: in vivo
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: in vivo
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Carcinogenicity

Data not provided by the registrant

Toxicity to reproduction

Data not provided by the registrant

Neurotoxicity

Data not provided by the registrant

Immunotoxicity

Data not provided by the registrant

Endocrine disrupter mammalian screening - in vivo

Data not provided by the registrant